Search

Your search keyword '"Shepherd, Frances A."' showing total 1,940 results

Search Constraints

Start Over You searched for: Author "Shepherd, Frances A." Remove constraint Author: "Shepherd, Frances A."
1,940 results on '"Shepherd, Frances A."'

Search Results

151. Mice with diverse microbial exposure histories as a model for preclinical vaccine testing

152. Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy

153. Prognostic and Predictive Effect of TP53 Mutations in Patients with Non–Small Cell Lung Cancer from Adjuvant Cisplatin–Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis

155. A Multicenter, Phase 2 Study of Vascular Endothelial Growth Factor Trap (Aflibercept) in Platinum- and Erlotinib-Resistant Adenocarcinoma of the Lung

157. Phase II Study of Accelerated Hypofractionated Three-Dimensional Conformal Radiotherapy for Stage T1-3 N0 M0 Non–Small Cell Lung Cancer: NCIC CTG BR.25

170. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial

174. Treatment patterns and outcomes of patients with advanced pleural mesothelioma at an academic referral centre

175. Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity

176. Abstract 563: cfDNA-based analysis of minimal residual disease and T-cell receptor clonality as predictors of relapse in stage 3 NSCLC treated with chemoradiotherapy and durvalumab

178. Durability of CNS disease control in NSCLC patients with brain metastases treated with immune checkpoint inhibitors plus cranial radiotherapy

189. Elderly patients with unresectable stage 3 NSCLC treated with definitive chemoradiation with or without durvalumab: Safety and outcomes.

190. The value of defining molecular resistance in patients with progressive EGFR and ALK-driven lung cancer in a public system.

191. Impact of KRAS mutational variant on response to immunotherapy in metastatic NSCLC.

192. Sequencing of systemic therapies in advanced NSCLC with MET exon 14 skipping mutation: A multicenter experience.

193. Preliminary results of BEAVER: An investigator-initiated phase II study of binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations (mts).

194. Nucleocapsid vaccine elicits spike-independent SARS-CoV-2 protective immunity

195. Gene expression--based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

199. A drug discovery platform to identify compounds that inhibit EGFR triple mutants

200. Protein-altering germline mutations implicate novel genes related to lung cancer development

Catalog

Books, media, physical & digital resources